Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,812 | -3,854 | 1,856 | 4,354 | 1,268 |
| Depreciation Amortization | 8,665 | 4,307 | 16,058 | 11,797 | 7,825 |
| Accounts receivable | -2,796 | -46 | -3,489 | -3,553 | -1,915 |
| Accounts payable and accrued liabilities | -8,658 | -6,227 | 8,966 | 1,100 | 2,182 |
| Other Working Capital | -8,588 | -12,064 | -23,319 | -28,815 | -17,649 |
| Other Operating Activity | 27,609 | 14,763 | 27,949 | 26,144 | 14,597 |
| Operating Cash Flow | $4,420 | $-3,121 | $28,021 | $11,027 | $6,308 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,725 | -12,918 | 28,158 | 9,787 | 5,258 |
| PPE Investments | -15,921 | -7,053 | -40,295 | -31,212 | -19,706 |
| Net Acquisitions | -3,871 | -1,904 | -7,119 | -5,127 | -3,362 |
| Investing Cash Flow | $-41,517 | $-21,875 | $-19,256 | $-26,552 | $-17,810 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4 | 0 | -1,467 | -1,466 | -1,466 |
| Common Stock Issued | 5,426 | 3,041 | 12,166 | 9,993 | 8,170 |
| Financing Cash Flow | $5,422 | $3,041 | $10,699 | $8,527 | $6,704 |
| Beginning Cash Position | 56,984 | 56,984 | 37,520 | 37,520 | 37,520 |
| End Cash Position | 25,309 | 35,029 | 56,984 | 30,522 | 32,722 |
| Net Cash Flow | $-31,675 | $-21,955 | $19,464 | $-6,998 | $-4,798 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,420 | -3,121 | 28,021 | 11,027 | 6,308 |
| Capital Expenditure | -15,921 | -7,053 | -40,295 | -31,212 | -19,706 |
| Free Cash Flow | -11,501 | -10,174 | -12,274 | -20,185 | -13,398 |